Search

Breakthrough Pancreatic Cancer Treatment Phase III Trial Opens in Israel

Hope is that successful trials will allow Rafael Pharmaceuticals will receive expedited FDA approval by late 2020.


READ ARTICLE by Maayan Jaffe-Hoffman. Published by The Jerusalem Post, July 18, 2019.


Cancer cells [illustrative]. (photo credit: PIXABAY)

Israel Investment Fund Group, LLC

8950 W Olympic Blvd, Ste 377

Beverly Hills, CA  90211

USA

Send Us a Message

© Israel Investment Fund Group, LLC